Form 8-K - Current report:
SEC Accession No. 0001193125-12-208469
Filing Date
2012-05-03
Accepted
2012-05-03 16:10:55
Documents
2
Period of Report
2012-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d343149d8k.htm 8-K 15358
2 EX-99.1 d343149dex991.htm EX-99.1 48859
  Complete submission text file 0001193125-12-208469.txt   65428
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 12809816
SIC: 2835 In Vitro & In Vivo Diagnostic Substances